Cite
HARVARD Citation
Provencio, M. et al. (2020). Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. Lancet oncology. 21 (11), pp. 1413-1422. [Online].